14.31
price up icon7.67%   1.02
after-market アフターアワーズ: 14.50 0.19 +1.33%
loading
前日終値:
$13.29
開ける:
$13.17
24時間の取引高:
4.49M
Relative Volume:
2.42
時価総額:
$1.73B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-7.4921
EPS:
-1.91
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+7.27%
1か月 パフォーマンス:
-5.48%
6か月 パフォーマンス:
-40.55%
1年 パフォーマンス:
-66.99%
1日の値動き範囲:
Value
$12.98
$14.56
1週間の範囲:
Value
$12.95
$14.56
52週間の値動き範囲:
Value
$12.95
$57.90

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1195)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,259
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

TXG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG 14.31 1.73B 631.73M -239.78M -33.45M -1.91
VEEV 216.58 35.07B 2.57B 615.26M 996.76M 3.32
SOLV 70.81 12.23B 8.26B 66.00M 1.17B 0.00
DOCS 48.20 9.00B 493.63M 160.55M 162.20M 0.55
TEM 58.60 9.23B 640.44M -743.28M -206.93M 0.00
HQY 104.25 8.98B 1.10B 105.67M -197.98M 0.1475

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
08:11 AM

Primecap Management Co. CA Grows Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

08:11 AM
pulisher
Nov 22, 2024

10x Genomics Inc (TXG) Shares Up 4.21% on Nov 22 - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

CIBC Asset Management Inc Sells 79,321 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Brown Capital Management LLC - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay Workflows - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

10 Best Genomics Stocks To Buy Right Now - Insider Monkey

Nov 20, 2024
pulisher
Nov 19, 2024

10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

LMR Partners LLP Invests $1.59 Million in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 19, 2024
pulisher
Nov 15, 2024

10X Genomics stock hits 52-week low at $13.98 amid market shifts - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

10x Genomics (NASDAQ:TXG) Hits New 52-Week LowWhat's Next? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Relative Strength Alert For 10x Genomics - Nasdaq

Nov 14, 2024
pulisher
Nov 14, 2024

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

10X Genomics' SWOT analysis: genomics firm's stock faces headwinds, eyes recovery - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Sumitomo Mitsui Trust Group Inc. Grows Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Nikko Asset Management Americas, Inc. Expands Stake in 10x Genomics Inc. - GuruFocus.com

Nov 09, 2024
pulisher
Nov 08, 2024

TXG10x Genomics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference - BioSpace

Nov 08, 2024
pulisher
Nov 08, 2024

ARK Investment Management LLC Purchases 1,436,582 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference – Company Announcement - Financial Times

Nov 07, 2024
pulisher
Nov 05, 2024

10x Genomics Announces Preliminary Select Third Quarter 2024 Res - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

10x Genomics Reports Third Quarter 2024 Financial Results - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

10x Genomics Announces Mega-Scale Single Cell Analysis for One C - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Sumitomo Mitsui Trust Group's Strategic Acquisition in 10x Genomics Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

10x Genomics Inc (TXG) Trading 2.45% Higher on Nov 4 - GuruFocus.com

Nov 04, 2024
pulisher
Nov 01, 2024

Barclays Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Brokers Set Expectations for 10x Genomics FY2024 Earnings - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Allspring Global Investments Holdings LLC Has $880,000 Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - PR Newswire

Oct 31, 2024
pulisher
Oct 31, 2024

10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

10x Genomics Third Quarter 2024 Earnings: EPS Beats Expectations - Simply Wall St

Oct 31, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30 - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Citigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $23.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Canaccord keeps 10X Genomics shares at Buy list - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics (NASDAQ:TXG) Issues Earnings Results - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics: Q3 Earnings Snapshot - The Advocate

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook - Investing.com

Oct 30, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics falls 7% on 2024 revenue guidance cut - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Inc Reports Q3 2024 Revenue of $151.7 Million, Missing Estimates; Gross Margin Improves to 70% - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook By Investing.com - Investing.com UK

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times

Oct 29, 2024
pulisher
Oct 29, 2024

Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance

Oct 29, 2024
pulisher
Oct 24, 2024

10X Genomics' SWOT analysis: stock faces headwinds amid strong consumables demand - Investing.com India

Oct 24, 2024

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
health_information_services WGS
$78.71
price up icon 9.21%
$22.84
price up icon 1.87%
$21.56
price up icon 2.28%
$18.75
price up icon 0.00%
health_information_services WAY
$31.25
price up icon 0.35%
health_information_services HQY
$104.25
price down icon 0.38%
大文字化:     |  ボリューム (24 時間):